Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

Analog 23 is a promising compound for prostate cancer treatment.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

HIV can cause skin disorders, which are often the first sign of infection, especially in people with darker skin.

Dermal EZH2 controls skin cell development and hair growth in mice.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Skin stem cells remember past inflammation, helping them respond better to future injuries and possibly aiding in treating skin issues.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Asian women with breast cancer experience the highest rates of long-term hair loss and related distress after chemotherapy.

UV photography can help identify people at higher risk for skin cancer, and male pattern baldness at age 45 is linked to a higher risk of certain skin cancers.

Understanding hair follicles can lead to new treatments for hair loss and skin tumors.

Both scalp cooling and chemical cooling caps effectively prevent hair loss in breast cancer patients undergoing chemotherapy.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Deleting Smad4 and PTEN genes in mice causes rapid, invasive forestomach cancer.

Ezh2 controls skin development by balancing signals for dermal and epidermal growth.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

Cosmetics can help with mild skin problems and daily care but must be used carefully to avoid skin irritation.

Grape seed extract is good for skin care, with antioxidant, anti-inflammatory, and anti-cancer effects.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

The Hedgehog signaling pathway is linked to cancer development, and targeting it with inhibitors shows promise but faces challenges like resistance.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.